Literature DB >> 16345024

Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia.

Juan C Salazar1, Frederick A Schmitt, Lei Yu, Marta M Mendiondo, Richard J Kryscio.   

Abstract

Multi-state models are appealing tools for analysing data about the progression of a disease over time. In this paper, we consider a multi-state Markov chain with two competing absorbing states: dementia and death and three transient non-demented states: cognitively normal, amnestic mild cognitive impairment (amnestic MCI), and non-amnestic mild cognitive impairment (non-amnestic MCI). The likelihood function for the data is derived and estimates for the effects of the covariates on transitions are determined when the process can be viewed as a polytomous logistic regression model with shared random effects. The presence of a shared random effect not only complicates the formulation of the likelihood but also its evaluation and maximization. Three approaches for maximizing the likelihood are compared using a simulation study; the first method is based on the Gauss-quadrature technique, the second method is based on importance sampling ideas, and the third method is based on an expansion by Taylor series. The best approach is illustrated using a longitudinal study on a cohort of cognitively normal subjects, followed annually for conversion to mild cognitive impairment (MCI) and/or dementia, conducted at the Sanders Brown Center on Aging at the University of Kentucky. 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 16345024     DOI: 10.1002/sim.2437

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Non-homogeneous Markov process models with informative observations with an application to Alzheimer's disease.

Authors:  Baojiang Chen; Xiao-Hua Zhou
Journal:  Biom J       Date:  2011-04-14       Impact factor: 2.207

2.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

3.  Markov Transition Model to Dementia with Death as a Competing Event.

Authors:  Shaoceng Wei; Liou Xu; Richard J Kryscio
Journal:  Comput Stat Data Anal       Date:  2014-12-01       Impact factor: 1.681

4.  A comparison of non-homogeneous Markov regression models with application to Alzheimer's disease progression.

Authors:  R A Hubbard; X H Zhou
Journal:  J Appl Stat       Date:  2011       Impact factor: 1.404

5.  Multi-stage transitional models with random effects and their application to the Einstein aging study.

Authors:  Changhong Song; Lynn Kuo; Carol A Derby; Richard B Lipton; Charles B Hall
Journal:  Biom J       Date:  2011-10-21       Impact factor: 2.207

6.  Markov chains and semi-Markov models in time-to-event analysis.

Authors:  Erin L Abner; Richard J Charnigo; Richard J Kryscio
Journal:  J Biom Biostat       Date:  2013-10-25

7.  A nonstationary Markov transition model for computing the relative risk of dementia before death.

Authors:  Lei Yu; William S Griffith; Suzanne L Tyas; David A Snowdon; Richard J Kryscio
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

8.  Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Authors:  Peter T Nelson; Gregory A Jicha; Frederick A Schmitt; Huaichen Liu; Daron G Davis; Marta S Mendiondo; Erin L Abner; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2007-12       Impact factor: 3.685

9.  Semi-Markov models for interval censored transient cognitive states with back transitions and a competing risk.

Authors:  Shaoceng Wei; Richard J Kryscio
Journal:  Stat Methods Med Res       Date:  2014-05-11       Impact factor: 3.021

10.  Estimating dementia-free life expectancy for Parkinson's patients using Bayesian inference and microsimulation.

Authors:  Ardo van den Hout; Fiona E Matthews
Journal:  Biostatistics       Date:  2009-07-31       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.